Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| IVVD | Invivyd | $2.44 | $0.67 | 37.57% | 80M | $412.6M | $0.35$2.74 |
| TOI | Oncology Institute | $3.92 | $0.84 | 27.30% | 2.6M | $288.0M | $0.13$4.88 |
| SRRK | Scholar Rock | $37.85 | $7.78 | 25.86% | 2.5M | $2.9B | $22.71$46.98 |
| CYCU | Cycurion | $5.07 | $0.89 | 21.24% | 1.6M | $12.1M | $2.15$2,045.10 |
| PGEN | Precigen | $4.64 | $0.78 | 20.21% | 2.9M | $1.2B | $0.65$5.23 |
| ENGS | Energys Group | $1.94 | $0.32 | 19.75% | 362.7K | $23.1M | $1.05$12.48 |
| AVDL | Avadel Pharmaceuticals Plc | $23.02 | $3.78 | 19.62% | 5.8M | $1.9B | $6.38$23.39 |
| FIGR | Figure Technology Solutions | $41.26 | $6.67 | 19.28% | 2M | $7.3B | $25.00$49.50 |
| AMPG | AmpliTech Group | $3.15 | $0.49 | 18.42% | 30K | $54.9M | $0.78$6.43 |
| OMER | Omeros | $7.27 | $0.99 | 15.72% | 1.1M | $427.4M | $2.95$13.60 |
Related Articles
Featured Article
This Healthcare Stock Is Up 1,000%, Outpacing Nvidia, Tesla, and Apple Combined
Lawrence Rothman|Oct 21, 2025
Can Oncology Institute's stock continue rewarding investors?
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?
Cory Renauer|Oct 16, 2025
Find out if the deal Omeros announced is enough of a reason to buy this stock.
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts
Cory Renauer|Sep 7, 2025
Experts who follow these stocks think they can fly higher despite already gaining over 100% since the end of July.
This Stock Is Up by 800% This Year -- but Is It a Buy?
Prosper Junior Bakiny|Jul 31, 2025
This little-known biotech might still deliver strong returns.
Here's Why Everybody's Talking About Scholar Rock Right Now
Cory Renauer|Oct 9, 2024
Successful clinical-trial results recently made Scholar Rock one of the stock market's top performers.
2 Incredible Growth Stocks to Buy Hand Over Fist
George Budwell|May 8, 2024
These two healthcare growth stocks could have a lot more room to run.
Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?
Cory Renauer|Dec 23, 2023
The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
Alex Carchidi|Mar 17, 2023
Biotechs are capable of making huge gains in short periods, and they often do.
These 2 Nasdaq Biotech Stocks Are Soaring Wednesday Morning
Dan Caplinger|Mar 30, 2022
Markets looked to take a breather after a huge surge in recent weeks.
Should Adagio Say Goodbye to Its COVID-19 Hopes?
Keith Speights and Brian Orelli, PhD|Jan 1, 2022
The prospects for Adagio's experimental COVID antibody therapy appear to be bleak.
